ADMA-43.37%20.0%
DYN-16.31%20.0%
INSM-42.27%20.0%
IONS-45.27%20.0%
NBIX-0.41%20.0%
As of Oct 9, 2026, 4:27 AM ET
Rare Diseases '25: RNA Therapy & Protein Mod Constituents
ADMA Biologics, Inc.ADMA | 20.0% | 1.87% | 2.08% | 9.31% | 4.03% | -43.37% | -33.65% | -48.94% | -29.92% | -50.14% | 822.32% | $2.39B |
Dyne Therapeutics, Inc.DYN | 20.0% | 2.50% | 0.18% | -14.70% | 3.48% | -16.31% | 4.80% | 65.19% | 11.51% | -50.59% | 14.48% | $3.06B |
Insmed IncorporatedINSM | 20.0% | -1.24% | -14.61% | -21.99% | -7.47% | -42.27% | -32.71% | 36.82% | -38.88% | 40.79% | 253.06% | $21.78B |
Ionis Pharmaceuticals, Inc.IONS | 20.0% | -1.95% | -4.98% | -22.71% | -1.59% | -45.27% | -46.64% | 50.82% | -38.38% | 14.55% | 27.02% | $7.20B |
Neurocrine Biosciences, Inc.NBIX | 20.0% | -1.55% | 0.58% | -8.95% | 0.38% | -0.41% | 6.81% | 30.41% | 2.01% | 26.50% | 35.71% | $14.20B |
| Theme return | — | -0.07% | -3.35% | -13.25% | -0.54% | -27.01% | -18.61% | 36.75% | -13.04% | 5.86% | 241.27% | — |
| Average | 20.0% | -0.07% | -3.35% | -11.81% | -0.23% | -29.53% | -20.28% | 26.86% | -18.73% | -3.78% | 230.52% | $9.73B |
| Median | 20.0% | -1.24% | 0.18% | -14.70% | 0.38% | -42.27% | -32.71% | 36.82% | -29.92% | 14.55% | 35.71% | $7.20B |
| Std Dev | 0.0% | 1.87% | 6.11% | 11.70% | 4.16% | 18.02% | 21.87% | 39.75% | 21.27% | 38.94% | 308.80% | $7.35B |
| Min | 20.0% | -1.95% | -14.61% | -22.71% | -7.47% | -45.27% | -46.64% | -48.94% | -38.88% | -50.59% | 14.48% | $2.39B |
| Max | 20.0% | 2.50% | 2.08% | 9.31% | 4.03% | -0.41% | 6.81% | 65.19% | 11.51% | 40.79% | 822.32% | $21.78B |
| % Positive Tickers | 40.00% | 60.00% | 20.00% | 60.00% | 0.00% | 40.00% | 80.00% | 40.00% | 60.00% | 100.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondaryWgt ↓ · Scroll right · Tap headers to sort